133 related articles for article (PubMed ID: 19929426)
1. IVS4-14 A/G and IVS4-73 C/T polymorphisms in OLR1 gene in patients with ischemic cerebrovascular diseases.
Vietri MT; Molinari AM; Boggia M; Parisi M; Cioffi M
Genet Test Mol Biomarkers; 2010 Feb; 14(1):9-11. PubMed ID: 19929426
[TBL] [Abstract][Full Text] [Related]
2. Are IVS4 SNPs of OLR1 gene associated with coronary artery disease: Is there a linkage between IVS4 SNPs?
Kurnaz-Gomleksiz O; Kucukhuseyin O; Ozkok E; Bugra Z; Ozturk O; Yilmaz-Aydogan H
Adv Clin Exp Med; 2018 Mar; 27(3):321-326. PubMed ID: 29558038
[TBL] [Abstract][Full Text] [Related]
3. G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke.
Hattori H; Sonoda A; Sato H; Ito D; Tanahashi N; Murata M; Saito I; Watanabe K; Suzuki N
Brain Res; 2006 Nov; 1121(1):246-9. PubMed ID: 17022953
[TBL] [Abstract][Full Text] [Related]
4. Role of six single nucleotide polymorphisms, risk factors in coronary disease, in OLR1 alternative splicing.
Tejedor JR; Tilgner H; Iannone C; Guigó R; Valcárcel J
RNA; 2015 Jun; 21(6):1187-202. PubMed ID: 25904137
[TBL] [Abstract][Full Text] [Related]
5. Oxidized LDL receptor 1 gene polymorphism in patients with metabolic syndrome.
Palmieri VO; Coppola B; Grattagliano I; Casieri V; Cardinale G; Portincasa P; Palasciano G; Di Serio F
Eur J Clin Invest; 2013 Jan; 43(1):41-8. PubMed ID: 23134583
[TBL] [Abstract][Full Text] [Related]
6. Association of LOXIN, a new functional splicing isoform of the OLR1 gene, with severity and prognostic localization of critical coronary artery stenoses.
Cappelletti A; Zanussi M; Mazzavillani M; Magni V; Calori G; Godino C; Ferrari M; Margonato A
J Cardiovasc Med (Hagerstown); 2014 May; 15(5):391-6. PubMed ID: 24743687
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction.
Mango R; Biocca S; del Vecchio F; Clementi F; Sangiuolo F; Amati F; Filareto A; Grelli S; Spitalieri P; Filesi I; Favalli C; Lauro R; Mehta JL; Romeo F; Novelli G
Circ Res; 2005 Jul; 97(2):152-8. PubMed ID: 15976314
[TBL] [Abstract][Full Text] [Related]
8. Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population.
Guo X; Xiang Y; Yang H; Yu L; Peng X; Guo R
J Atheroscler Thromb; 2017 Jun; 24(6):572-582. PubMed ID: 27840386
[TBL] [Abstract][Full Text] [Related]
9. On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease.
Trabetti E; Biscuola M; Cavallari U; Malerba G; Girelli D; Olivieri O; Martinelli N; Corrocher R; Pignatti PF
Eur J Hum Genet; 2006 Jan; 14(1):127-30. PubMed ID: 16251892
[TBL] [Abstract][Full Text] [Related]
10. Loxin polymorphism is associated with increased resistin levels and with oxidative status.
Gambino R; Bo S; Musso G; Pagano G; Cassader M
Clin Biochem; 2011 Aug; 44(12):1015-7. PubMed ID: 21679701
[TBL] [Abstract][Full Text] [Related]
11. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization.
Biocca S; Filesi I; Mango R; Maggiore L; Baldini F; Vecchione L; Viola A; Citro G; Federici G; Romeo F; Novelli G
J Mol Cell Cardiol; 2008 Mar; 44(3):561-70. PubMed ID: 18191942
[TBL] [Abstract][Full Text] [Related]
12. The 3'-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease.
Sentinelli F; Filippi E; Fallarino M; Romeo S; Fanelli M; Buzzetti R; Berni A; Baroni MG
Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):345-52. PubMed ID: 16829343
[TBL] [Abstract][Full Text] [Related]
13. Genotyping OLR1 gene: a genomic biomarker for cardiovascular diseases.
Vecchione L; Gargiul E; Borgiani P; Predazzi I; Mango R; Romeo F; Magnani M; Novelli G
Recent Pat Cardiovasc Drug Discov; 2007 Jun; 2(2):147-51. PubMed ID: 18221114
[TBL] [Abstract][Full Text] [Related]
14. LOX-1 gene variants and maternal levels of plasma oxidized LDL and malondialdehyde in patients with gestational diabetes mellitus.
Aydemir B; Baykara O; Cinemre FB; Cinemre H; Tuten A; Kiziler AR; Akdemir N; Oncul M; Kaya B; Sozer V; Erkorkmaz U; Uzun H
Arch Gynecol Obstet; 2016 Mar; 293(3):517-27. PubMed ID: 26296941
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of LOXIN Protects Endothelial Progenitor Cells From Apoptosis Induced by Oxidized Low Density Lipoprotein.
Veas C; Jara C; Willis ND; Pérez-Contreras K; Gutierrez N; Toledo J; Fernandez P; Radojkovic C; Zuñiga FA; Escudero C; Aguayo C
J Cardiovasc Pharmacol; 2016 Apr; 67(4):326-35. PubMed ID: 26771151
[TBL] [Abstract][Full Text] [Related]
16. LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.
Rizzacasa B; Morini E; Pucci S; Murdocca M; Novelli G; Amati F
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146073
[TBL] [Abstract][Full Text] [Related]
17. LOX-1/LOXIN: the yin/yang of atheroscleorosis.
Mango R; Predazzi IM; Romeo F; Novelli G
Cardiovasc Drugs Ther; 2011 Oct; 25(5):489-94. PubMed ID: 21904818
[TBL] [Abstract][Full Text] [Related]
18. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
Mehta JL
Can J Cardiol; 2004 Aug; 20 Suppl B():32B-36B. PubMed ID: 15309203
[TBL] [Abstract][Full Text] [Related]
19. LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation.
Pothineni NVK; Karathanasis SK; Ding Z; Arulandu A; Varughese KI; Mehta JL
J Am Coll Cardiol; 2017 Jun; 69(22):2759-2768. PubMed ID: 28571642
[TBL] [Abstract][Full Text] [Related]
20. The human rs1050286 polymorphism alters LOX-1 expression through modifying miR-24 binding.
Morini E; Rizzacasa B; Pucci S; Polidoro C; Ferrè F; Caporossi D; Helmer Citterich M; Novelli G; Amati F
J Cell Mol Med; 2016 Jan; 20(1):181-7. PubMed ID: 26542080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
